MERCK Kommanditgesellschaft auf Aktien (id:2553 MRK)
137.85 EUR
Opening hours: 09:00 - 17:30 (Central European Standard Time: 12/25/2024 4:12:27 PM)
Exchange open, closes in 1 hour 17 minutes
About MERCK Kommanditgesellschaft auf Aktien
Market Capitalization 59.56B
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies. Its Healthcare segment discovers, develops, manufacturers, and markets prescription drugs and biopharmaceuticals for the treatment of oncology, neurology and immunology, fertility, endocrinology, as well as cardiovascular, diabetes, thyroid disorders, and multiple sclerosis; general medicines; and injection device and disease monitoring software. The Electronics segment supplies materials for the semiconductor and display industries and surface design, such as delivery systems and services, as well as surface solutions, including cosmetics, effect pigments, and functional solutions. In addition, it has in-licensing agreement with Debiopharm International SA for developing and commercializing drug candidates for the treatment of head and neck cancer; Jiangsu Hengrui Pharmaceuticals Co. Ltd. for developing, manufacturing, and commercializing drug candidates for the treatment of metastatic colorectal cancer; and Abbisko Therapeutics Co. Ltd. for developing and commercializing of drug candidates for the treatment of tenosynovial giant cell tumor, as well as license and collaboration agreement with Merck KGaA to discover two targeted protein degraders against critical oncogenic proteins. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KGaA.
| Headquarters (address) |
Frankfurter Strasse 250 Darmstadt 64293 Germany |
| Phone | 49 6151 72 0 |
| Website | https://www.merckgroup.com/en |
| Employees | 62K |
| Sector | Healthcare |
| Industry | Drug Manufacturers Specialty & Generic |
| Ticker | MRK |
| Exchange | Xetra Frankfurt Stock Exchange |
| Currency | EUR |
| 52 week range | 136.10 - 177.00 |
| Market Capitalization | 59.56B |
| Dividend yield forward | 6.38 % |
| Dividend yield forward Germany (ID:66, base:265) | 13.16 % |
| P/E trailing | 22.13 |
| P/E forward | 14.02 |
| Price/Sale | 2.85 |
| Price/Book | 2.23 |
| Beta | 3.00 |
| EPS | 6.19 |
| EPS Germany (ID:66, base:318) | 2.39 |
Dividend growth streak
MERCK Kommanditgesellschaft auf Aktien has raised their dividend 4.00 years in a row. This is below the 4.499729 year average in the 'Drug Manufacturers Specialty & Generic' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: MERCK Kommanditgesellschaft auf Aktien has raised their dividend 6.38 years in a row. This is below the 42132.505700 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: MERCK Kommanditgesellschaft auf Aktien has raised their dividend 19.17 years in a row. This is below the 23.957000 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: MERCK Kommanditgesellschaft auf Aktien has raised their dividend 11.97 years in a row. This is below the 12.560500 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: MERCK Kommanditgesellschaft auf Aktien has raised their dividend 2.61 years in a row. This is below the 10.207200 year average in the 'Drug Manufacturers Specialty & Generic' industry
Payout Ratio
Payout Ratio: MERCK Kommanditgesellschaft auf Aktien has raised their dividend 36.48 years in a row. This is below the 148.467900 year average in the 'Drug Manufacturers Specialty & Generic' industry
Self funded year
MERCK Kommanditgesellschaft auf Aktien years needed to self fund. This is below the 34.112811 year average in the 'Drug Manufacturers Specialty & Generic' industry
Dividend growth streak
MERCK Kommanditgesellschaft auf Aktien has raised their dividend 4.00 years in a row. This is below the 4.499729 year average in the 'Drug Manufacturers Specialty & Generic' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: MERCK Kommanditgesellschaft auf Aktien has raised their dividend 6.38 years in a row. This is below the 42132.505700 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: MERCK Kommanditgesellschaft auf Aktien has raised their dividend 19.17 years in a row. This is below the 23.957000 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: MERCK Kommanditgesellschaft auf Aktien has raised their dividend 11.97 years in a row. This is below the 12.560500 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: MERCK Kommanditgesellschaft auf Aktien has raised their dividend 2.61 years in a row. This is below the 10.207200 year average in the 'Drug Manufacturers Specialty & Generic' industry
Payout Ratio
Payout Ratio: MERCK Kommanditgesellschaft auf Aktien has raised their dividend 36.48 years in a row. This is below the 148.467900 year average in the 'Drug Manufacturers Specialty & Generic' industry
Self funded year
MERCK Kommanditgesellschaft auf Aktien years needed to self fund. This is below the 34.112811 year average in the 'Drug Manufacturers Specialty & Generic' industry